HER2-positive Locally Advanced or Metastatic Breast Cancer
1 competing product in clinical development for HER2-positive Locally Advanced or Metastatic Breast Cancer.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab + Pertuzumab + Docetaxel + Paclitaxel + Nab-paclitaxel + Vinorelbine + Eribulin + Capecitabine + Gemcitabine | Chugai Pharmaceutical | Phase 3 | Completed | 40 |